Intellipharmaceutics International Inc. (OTCMKTS:IPCIF – Get Free Report) (TSE:I)’s share price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.06 and traded as high as $0.11. Intellipharmaceutics International shares last traded at $0.07, with a volume of 4,160 shares.
Intellipharmaceutics International Price Performance
The business’s 50 day moving average price is $0.06 and its 200 day moving average price is $0.06. The stock has a market capitalization of $2.32 million, a P/E ratio of -0.44 and a beta of 1.07.
About Intellipharmaceutics International
Intellipharmaceutics International Inc, a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. It develops various drug delivery systems, product candidates, and a pipeline of products based on its patented Hypermatrix technology in various therapeutic areas, including neurology, cardiovascular, gastrointestinal tract, diabetes, and pain.
Featured Stories
- Five stocks we like better than Intellipharmaceutics International
- Manufacturing Stocks Investing
- Comprehensive PepsiCo Stock Analysis
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- High Flyers: 3 Natural Gas Stocks for March 2022
- Bear Market Funds to Watch This Year
Receive News & Ratings for Intellipharmaceutics International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intellipharmaceutics International and related companies with MarketBeat.com's FREE daily email newsletter.
